Lineage Cell Therapeutics Inc (LCTX)
1.145
-0.06
(-4.58%)
USD |
NYAM |
Apr 19, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Cash from Investing (TTM): 46.45M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.45M |
| September 30, 2023 | 31.60M |
| June 30, 2023 | -11.43M |
| March 31, 2023 | -30.69M |
| December 31, 2022 | -46.16M |
| September 30, 2022 | -41.20M |
| June 30, 2022 | -0.357M |
| March 31, 2022 | -0.375M |
| December 31, 2021 | 9.745M |
| September 30, 2021 | 10.79M |
| June 30, 2021 | 11.04M |
| March 31, 2021 | 17.86M |
| December 31, 2020 | 13.04M |
| September 30, 2020 | 12.86M |
| June 30, 2020 | 26.16M |
| March 31, 2020 | 19.27M |
| December 31, 2019 | 16.96M |
| September 30, 2019 | 26.02M |
| June 30, 2019 | 12.40M |
| March 31, 2019 | 12.55M |
| December 31, 2018 | 11.82M |
| September 30, 2018 | 1.449M |
| June 30, 2018 | 1.329M |
| March 31, 2018 | 1.14M |
| December 31, 2017 | -10.22M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.05M |
| June 30, 2017 | -10.26M |
| March 31, 2017 | -18.38M |
| December 31, 2016 | -10.89M |
| September 30, 2016 | -13.07M |
| June 30, 2016 | -14.63M |
| March 31, 2016 | -8.733M |
| December 31, 2015 | -7.441M |
| September 30, 2015 | -5.062M |
| June 30, 2015 | -3.127M |
| March 31, 2015 | -0.8534M |
| December 31, 2014 | -1.008M |
| September 30, 2014 | -2.457M |
| June 30, 2014 | -3.582M |
| March 31, 2014 | -3.642M |
| December 31, 2013 | -3.665M |
| September 30, 2013 | -2.203M |
| June 30, 2013 | -1.037M |
| March 31, 2013 | -0.5381M |
| December 31, 2012 | -0.1047M |
| September 30, 2012 | -0.0888M |
| June 30, 2012 | -0.2797M |
| March 31, 2012 | -0.7819M |
| December 31, 2011 | -1.203M |
| September 30, 2011 | 2.882M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-46.16M
Minimum
Dec 2022
46.45M
Maximum
Dec 2023
6.525M
Average
12.40M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
| Acumen Pharmaceuticals Inc | -171.67M |
| Sarepta Therapeutics Inc | -165.80M |
| CEL-SCI Corp | -0.3835M |
| AIM ImmunoTech Inc | -0.832M |
| IGC Pharma Inc | -0.236M |